11 employees
Synspira Therapeutics is focused on developing a rationally designed portfolio of products in cystic fibrosis and other rare diseases.
2017
$14M
from 1 investors over 1 rounds
Synspira Therapeutics, Inc. raised $14M on October 20, 2020
Investors: Miller Family Holdings Trust